Look no further than the Zacks Style Scores. CORT's Cushing's syndrome drug, Korlym, is driving revenues. The NDA for relacorilant in Cushing's syndrome will be filed shortly. The average of price ...

Plane is Airworthy and ready to fly! Airplane can be Delivered ‘As Is Where Is’ for $1.875M (USD) or Delivered with Fresh C-Check for $2.575M (USD). Landing Gear are good until Feb 2021, but can be ...

CORT sits at a Zacks Rank #2 (Buy), holds a Momentum Style Score of B, and has a VGM Score of B. The stock is up 11% and up 21.7% over the past one-week and four-week period, respectively ...

Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Equities researchers at Zacks Research lifted their FY2024 EPS estimates for Corcept Therapeutics in a report released on ...

Check out our top picks from Steam Next Fest October 2024 for an idea of what to expect when the next sale arrives. The best Steam feature for keeping track of sales is your wishlist. Browsing ...

Current-Quarter Estimate Revisions The company is expected to earn $0.33 per share for the current quarter, which represents a year-over-year change of +17.86%. Over the last 30 days, the Zacks ...

R 250 000 2 Bedroom House Kwamhlanga Stand for sale in Kinspark Kwamhlanga with business opportunity This property offers; 2 Single rooms that can be rented out Fast ...